Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/1998
12/09/1998EP0882046A1 Quinolones and their therapeutic use
12/09/1998EP0882044A1 1,4-dihydropyridine compounds as bradykinin antagonists
12/09/1998EP0882016A1 Alkylated styrenes as prodrugs to cox-2 inhibitors
12/09/1998EP0882015A1 Diphenyl stilbenes as prodrugs to cox-2 inhibitors
12/09/1998EP0881914A1 Methoxyethoxy oligonucleotides for modulation of protein kinase c expression
12/09/1998EP0881899A2 Dosage form of ibuprofen
12/09/1998EP0712390B1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
12/09/1998EP0463073B1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA
12/09/1998EP0422186B1 Use of oncostatin m for suppressing mhc antigens
12/09/1998CN1041087C Arylacetamides, preparation method and use thereof
12/08/1998US5847135 Inhibitors of interleukin-1β converting enzyme
12/08/1998US5847107 Method of preparing mixed glucosamine salts
12/08/1998US5847004 Method for in vivo reduction of nitric oxide levels and compositions useful therefor
12/08/1998US5847000 Fatty acid derivatives
12/08/1998US5846998 Use of phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
12/08/1998US5846989 Benzothiazolone derivatives
12/08/1998US5846968 N-substituted azaheterocyclic carboxylic acids and esters
12/08/1998US5846965 3-aza and 3-oxa piperidone tachykinin antagonists
12/08/1998US5846959 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
12/08/1998US5846800 Nucleic acid molecules encoding a novel receptor-type protein tyrosine phosphatase-σ
12/08/1998US5846566 Microcapsules for the controlled release of acetylsalicylic acid in the gastrointestinal environment
12/08/1998CA2150129C Amino-substituted pyrazoles having crf antagonistic activity
12/08/1998CA2053209C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054222A1 Cyclic crf agonists
12/03/1998WO1998054207A1 Anti-inflammatory tyrosine derivatives
12/03/1998WO1998054202A1 Human tumor necrosis factor receptor tr10
12/03/1998WO1998054190A1 Novel compounds
12/03/1998WO1998054189A1 Spiro-quinuclidine derivatives, their preparation and use
12/03/1998WO1998054187A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/03/1998WO1998054182A1 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
12/03/1998WO1998054181A1 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors
12/03/1998WO1998054180A1 Novel compounds
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998054158A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/03/1998WO1998054157A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p561ck TYROSINE KINASES
12/03/1998WO1998054156A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES
12/03/1998WO1998054152A1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/03/1998WO1998054093A1 Novel angiogenesis inhibitors
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998053818A1 Sulfonamides as cell adhesion inhibitors
12/03/1998WO1998053817A1 Biarylalkanoic acids as cell adhesion inhibitors
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998038994A3 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998CA2292790A1 Human tumor necrosis factor receptor tr10
12/03/1998CA2291774A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291762A1 Biarylalkanoic acids as cell adhesion inhibitors
12/03/1998CA2291750A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291728A1 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
12/03/1998CA2291709A1 Novel angiogenesis inhibitors
12/03/1998CA2291708A1 Sulfonamides as cell adhesion inhibitors
12/03/1998CA2289578A1 Spiro-quinuclidine derivatives, their preparation and use
12/03/1998CA2289576A1 Azacyclooctane and heptane derivatives, their preparation and use in therapy
12/03/1998CA2289037A1 Spiro-azacyclic derivatives and their use as therapeutic agents
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881294A2 HOEFCC11, a HAS2 splicing variant
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0880970A1 Pharmaceutical compositions comprising an anticytokine
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880529A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880528A1 Spiro-ketal derivatives and their use as therapeutic agents
12/02/1998EP0880526A1 Heterocycle-condensed morphinoid derivatives (ii)
12/02/1998EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998EP0880522A1 5H,10H-IMIDAZO 1,2-a]INDENO 1,2-e]PYRAZINE-4-ONE DERIVATIVES, PREPARATION THEREOF, INTERMEDIATES THEREOF AND DRUGS CONTAINING SAME
12/02/1998EP0880519A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
12/02/1998EP0880517A1 Quinazoline compounds
12/02/1998EP0880504A1 Heterocyclo-substituted imidazoles for the treatment of inflammation
12/02/1998EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998EP0752875A4 Glioblastoma-derived angiogenesis inhibiting factor
12/02/1998EP0743953B1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase
12/02/1998EP0641200B1 2-arylpropionic acid compositions and process for preparing the same
12/02/1998CN1200737A Recombinant anti-CD4 antibodies for human therapy
12/02/1998CN1200730A Alternate crystal form of tazofelone
12/02/1998CN1200374A Vitronectin receptor antagonists, their prepn. and their use
12/02/1998CN1200373A Vitronectin receptor antagonists, their prepn. and use
12/02/1998CN1040982C Method for preparing pyranoquinoline and salts thereof
12/02/1998CN1040980C Second messenger cell signaling inhibitors
12/02/1998CA2238580A1 Cell adhesion inhibitors
12/01/1998US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998US5844074 Cyclic CRF agonists
12/01/1998US5844072 Antibiotic cryptdin peptides and methods of their use
12/01/1998US5844004 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
12/01/1998US5843999 2-phenylazulene derivatives and a manufacturing method of these compounds
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843966 Piperidine derivatives
12/01/1998US5843947 N-pyridyl carboxamides and derivatives
12/01/1998US5843943 Compounds for inhibition of ceramide-mediated signal transduction
12/01/1998US5843942 Aromatic amino ethers as pain relieving agents
12/01/1998US5843936 Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes
12/01/1998US5843935 Protein kinase C inhibitors
12/01/1998US5843910 Colchicine derivatives and the therapeutical use thereof
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843899 Use of insulin-like growth factors I and II for inhibition of inflammatory response
12/01/1998US5843727 Polynucleotides encoding a human tumor-associated membrane protein
12/01/1998US5843719 Cellubrevin homolog
12/01/1998US5843675 TNF receptor death domain ligand proteins and inhibitors of ligand binding
1 ... 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 ... 1272